LEIGHANN MONTOYA: Open Payments
NPI 1629724984 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 11 payments from 8 companies in 2025. Trend: 2023 $1,512 · 2024 $1,818 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $87 |
| CSL Behring | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Exelixis Inc. | 1 | $35 |
| Incyte Corporation | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Trodelvy, Afstyla, Stivarga, CABOMETYX, JAKAFI, Fabhalta, OPDIVO, ENHERTU.
Industry payments across FL — which companies pay providers there.
